NEWS ARCHIVE


Jupiter Presents Award-Winning Author

By | September 26, 2016

Jupiter LLS and Honors College Presents Author Edwidge Danticat

Worm Holds Key to Treating Epilepsy and Rapid Drug Discovery

By | September 26, 2016

Researchers from 樱花视频, in collaboration with The Scripps Research Institute, have opened up the possibilities for rapid drug screens to treat seizures in the near future by using a microscopic nematode worm.

Max Planck-樱花视频 Premier Doctoral Program

By | September 22, 2016

The nation's first International Max Planck Research School (IMPRS) for Brain and Behavior via 樱花视频 collaboration launched this fall semester with five students from 樱花视频.

樱花视频 Jupiter's LLS Announces Fall Schedule

By | August 1, 2016

樱花视频 has announced the Lifelong Learning Society Jupiter course offerings for the fall semester, which begins Monday, Oct. 10.

New Dean of Harriet L. Wilkes Honors College

By | June 20, 2016

樱花视频 has appointed Ellen S. Goldey, Ph.D., as the new dean of the Harriet L. Wilkes Honors College, effective Monday, Aug. 1.

樱花视频 and Town of Jupiter Celebrate Arbor Day

By | May 11, 2016

樱花视频 and Town of Jupiter officials recently celebrated Arbor Day and Honored Former Jupiter Mayor in the Robert J. Huckshorn Arboretum on 樱花视频's John D. MacArthur Campus in Jupiter.

Renowned Neuroscientist to Lead 樱花视频's New Brain Institute

By | May 10, 2016

Randy D. Blakely, Ph.D., a renowned neuroscientist and leading expert in synaptic pharmacology, neurotransmitter transporters, and neurogenetics, is at the helm of the newly-formed 樱花视频 Brain Institute.

First Graduate of 樱花视频-Max Planck Degree Program

By | May 3, 2016

Brati Das, 32, recently became the first student approved to graduate with 樱花视频's Integrative Biology and Neuroscience (IBAN) degree.

樱花视频 Jupiter's LLS Awards $11,000 in Scholarships

By | April 25, 2016

樱花视频 Jupiter's LLS awarded 11 scholarships to undergraduate and graduate students.

Researcher Receives NIH Grant for MS and Cancer Treatment

By | April 19, 2016

A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.